The role of the primary care physician in managing early stages of chronic kidney disease

Postgraduate Medicine

Volumn 123, Issue 5, 2011, Pages 177-185

  Coritsidis, George N ^a,b   Linden, Ellena ^a,b   Stern, Aaron S ^a,b  

^a ELMHURST HOSPITAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Chronic kidney disease mineral and bone disorder; Diabetes; Estimated glomerular fi ltration rate; Hypertension

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; EARLY DIAGNOSIS; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LABORATORY TEST; METABOLIC DISORDER; MICROALBUMINURIA; NEPHROLOGIST; PATIENT CARE; PATIENT REFERRAL; PERITONEAL DIALYSIS; PHYSICIAN ATTITUDE; PREVALENCE; PROTEINURIA; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EARLY DIAGNOSIS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PHYSICIAN'S ROLE; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK FACTORS;

EID: 80052748392     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.09.2473     Document Type: Article

References (63)

1. O'Malley AS, Reschovsky JD. Referral and consultation communication between primary care and specialist physicians: finding common ground. Arch Intern Med. 10;171(1):56-65.
2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-2047.
3. Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for chronic kidney disease. Part 4. Defi nition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39(2 suppl 1):S46-S75.
4. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):3736-3741.
5. U. S. Renal Data System. USRDS 2010 Annual Data Report, Volume 2: Atlas of End-Stage Renal Disease. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.
6. Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol. 2002; 13(5):1279-1287.
7. Lameire N, Van Biesen W. Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol. 2010;6(2): 75-82.
8. U. S. Renal Data System. USRDS 2008 Annual Data Report, Volume 1: Atlas of Chronic Kidney Disease. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
9. U. S. Renal Data System. USRDS 2008 Annual Data Report, Volume 2: Atlas of End-State Renal Disease. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
10. U.S. Renal Data System. USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
11. Navaneethan SD, Nigwekar S, Sengodan M, et al. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored? Nephron Clin Pract. 2007;106(3):c113-c118.
12. Winkelmayer WC, Mehta J, Chandraker A, Owen WF Jr, Avorn J. Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant. 2007;7(4):872-879.
13. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function- measured and estimated glomerular fi ltration rate. N Engl J Med. 2006; 354(23):2473-2483.
14. Seifter JL, Fuller AP. Consideration of extrarenal creatinine clearance in the measurement of renal function after bowel endoscopy. Arch Intern Med. 2008;168(19):2166-2167.
15. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
17. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modifi cation of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4): 247-254.
18. Wyatt C, Konduri V, Eng J, Rohatgi R. Reporting of estimated GFR in the primary care clinic. Am J Kidney Dis. 2007;49(5):634-641.
19. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17): 1890-1896.
20. Gill J, Malyuk R, Djurdjev O, Levin A. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group-a cautionary tale. Nephrol Dial Transplant. 2007;22(10):2894-2899.
21. Levey AS, Coresh J, Greene T, et al. Expressing the Modifi cation of Diet in Renal Disease Study equation for estimating glomerular fi ltration rate with standardized serum creatinine values. Clin Chem. 2007; 53(4):766-772.
22. Golik MV, Lawrence KR. Comparison of dosing recommendations for antimicrobial drugs based on two methods for assessing kidney function: Cockcroft-Gault and modifi cation of diet in renal disease. Pharmacotherapy. 2008;28(9):1125-1132.
23. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004;66(4):1596-1605.
24. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25(6):496-501.
25. Muntner P, Anderson A, Charleston J, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insuffi ciency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55(3): 441-451.
26. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12-S154.
27. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 2001;60(1):277-283.
28. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Progression of diabetic nephropathy. Kidney Int. 2001;59(2):702-709.
29. Drummond K, Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes. 2002;51(5):1580-1587.
30. Viberti GC, Friedman R. Predictive value of microalbuminuria in longstanding insulin dependent diabetes. BMJ. 1993;306(6872):271; author reply 272.
31. Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010;55(3):463-473.
32. Schaeffner ES, Kurth T, Bowman TS, Gelber RP, Gaziano JM. Blood pressure measures and risk of chronic kidney disease in men. Nephrol Dial Transplant. 2008;23(4):1246-1251.
33. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
34. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(suppl 113): S1-S130.
35. Lattanzio MR, Weir MR. Does blockade of the renin-angiotensinaldosterone system slow progression of all forms of kidney disease? Curr Hypertens Rep. 2010;12(5):369-377.
36. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075-2084.
37. Jüppner H. Phosphate and FGF-23. Kidney Int. 2011;79(suppl 121): S24-S27.
38. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 suppl 3): S1-S201.
39. Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71(1)31-38.
40. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137(6): 479-486.
41. Hasegawa T, Bragg-Gresham JL, Yamazaki S, et al. Greater fi rst-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. Clin J Am Soc Nephrol. 2009;4(3):595-602.
42. Furumatsu Y, Nagasawa Y, Yamamoto R, et al. Specialist care and improved long-term survival of dialysis patients. Nephrol Dial Transplant. 2010;25(6):1930-1935.
43. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identifi cation and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48(2):192-204.
44. Son YK, Oh JS, Kim SM, Jeon JM, Shin YH, Kim JK. Clinical outcome of preemptive kidney transplantation in patients with diabetes mellitus. Transplant Proc. 2010;42(9):3497-3502.
45. Haberal M, Karakayali H, Sevmis S, et al. Preemptive living donor renal transplantation: a single-center experience. Transplant Proc. 2009; 41(7):2764-2767.
46. McGill RL, Marcus RJ, Healy DA, Brouwer DJ, Smith BC, Sandroni SE. AV fi stula rates: changing the culture of vascular access. J Vasc Access. 2005;6(1):13-17.
47. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg. 1997;26(6):1009-1019.
48. Demoulin N, Beguin C, Labriola L, Jadoul M. Preparing renal replacement therapy in stage 4 CKD patients referred to nephrologists: a difficult balance between futility and insuffi ciency. A cohort study of 386 patients followed in Brussels. Nephrol Dial Transplant. 2011; 26(1):220-226.
49. Astor BC, Eustace JA, Powe NR, et al. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis. 2001;38(3):494-501.
50. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50(2):169-180.
51. Laliberté MC, Normandeau M, Lord A, et al. Use of over-the-counter medications and natural products in patients with moderate and severe chronic renal insufficiency. Am J Kidney Dis. 2007;49(2):245-256.
52. MacRae JM, Rose CL, Jaber BL, Gill JS. Utilization and outcome of 'out-of-center hemodialysis' in the United States: a contemporary analysis. Nephron Clin Pract. 2010;116(1):c53-c59.
53. Agrawal V, Ghosh AK, Barnes MA, McCullough PA. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. Am J Kidney Dis. 2008;52(6):1061-1069.
54. Minutolo R, De Nicola L, Mazzaglia G, et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: a crosssectional study from Italy. Am J Kidney Dis. 2008;52(3):444-453.
55. Saab G, Whaley-Connell AT, McCullough PA, Bakris GL. CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2008;52(2):382-383.
56. Ostbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005;3(3):209-214.
57. Pham HH, O'Malley AS, Bach PB, Saiontz-Martinez C, Schrag D. Primary care physicians' links to other physicians through Medicare patients: the scope of care coordination. Ann Intern Med. 2009;150(4): 236-242.
58. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4):635-641.
59. Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006;19(1):54-61.
60. Astor BC, Hallan SI, Miller ER, 3rd, Yeung E, Coresh J. Glomerular fi ltration rate, albuminuria, and risk of cardiovascular and allcause mortality in the US population. Am J Epidemiol. 2008;167(10): 1226-1234.
61. Wu IW, Wang SY, Hsu KH, et al. Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality- a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant. 2009;24(11):3426-3433.
62. Noble E, Johnson DW, Gray N, et al. The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant. 2008;23(12):3845-3850.
63. Isakova T, Gutiérrez OM, Chang Y, et al. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009;20(2):388-396.